Rimmyrah
Medicinal products may have risk minimisation materials that are intended to promote the safe and effective use of the medicinal product.
The materials on this site are targeted for patients.
Risk minimisation materials are produced by the marketing authorisation holder of the medicinal product. The content and dissemination of the materials are agreed with the national competent authority.
Wet (neovascular) age related macular degeneration (AMD)
Audio recording:
Patient information booklet:
Listen here (AMD)Proliferative diabetic retinopathy (PDR) / diabetic macular oedema (DMO)
Audio recording:
Patient information booklet:
Listen here (PDR/DMO)